The RobinCar Family: R tools for robust covariate adjustment in randomized clinical trials
Abstract Purpose Covariate adjustment is a powerful statistical technique that can increase efficiency in clinical trials. Recent guidance from the U.S. Food and Drug Association (FDA) provided recommendations and best practices for using covariate adjustment. However, there has existed a gap between the extensive statistical literature on covariate adjustment and software that is easy to use and abides by these best practices. Methods We have developed the RobinCar Family, which is comprised of RobinCar and RobinCar2. These two R packages enable covariate-adjusted analyses for continuous, discrete, and time-to-event outcomes that follow best practices. For continuous and discrete outcomes, the functions in the RobinCar Family facilitate traditional forms of covariate adjustment such as ANCOVA as well as more recent approaches like ANHECOVA, G-computation with generalized linear models and machine learning models, and adjustment for a super-covariate (as in PROCOVA™). Functions for time-to-event outcomes implement the covariate-adjusted log-rank test, the stratified covariate-adjusted log-rank test, and the marginal covariate-adjusted hazard ratio. The RobinCar Family is supported by the ASA Biopharmaceutical Section Covariate Adjustment Scientific Working Group. Results We provide an accessible overview of the covariate-adjusted statistical methods, and describe how they are implemented in RobinCar and RobinCar2. We highlight important usage notes for clinical trial practitioners. Conclusion We apply RobinCar and RobinCar2 functions by analyzing data from the AIDS Clinical Trials Group Study 175, demonstrating that they are straightforward and user-friendly.
Authors
- Gregory M. Chen (ORCID: https://orcid.org/0000-0002-4083-5083)
- Yanyao Yi (ORCID: https://orcid.org/0000-0003-1540-1862)
- Liming Li (ORCID: https://orcid.org/0009-0008-6870-0878)
- Yuanyuan Bian (ORCID: https://orcid.org/0000-0003-4736-2597)
- Ting Ye
- Yuhan Qian
- Dong Xi
- Daniel Sabanés Bové
- Marlena Bannick (ORCID: https://orcid.org/0000-0001-6797-5978)
- ASA-BIOP Covariate Adjustment Scientific Working Group
- on behalf of the Software Subteam
Institutions
- Eli Lilly (United States) (US)
- University of Washington (US)
- MSD (Switzerland) (CH)
- AstraZeneca (Brazil) (BR)
- Allgemeine Gewerbeschule Basel (CH)
- Gilead Sciences (United States) (US)
Publication Details
- Journal
- BMC Medical Research Methodology
- Published
- 2026-09-19
- DOI
- https://doi.org/10.1186/s12874-026-03000-1
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 0.00